James F. Reddoch, EVP, Research & Investments at Royalty Pharma plc (RPRX), sold 87,854 shares at $46.32 ($4.1M) on 2021-03-22, disclosed to the SEC on 2021-03-24.
Open-market sale of $4.1M RPRX by EVP, Research & Investments. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.32 | 43,927 | $2.0M | 50.0% |
| 2 | $46.32 | 43,927 | $2.0M | 50.0% |
| Total | $46.32 avg | 87,854 | $4.1M | 100% |
| Filing → |
| RPRX | SELL | 2022-05-31 | $3.1M | — | Filing → |
| RPRX | SELL | 2022-05-23 | $3.0M | — | Filing → |
| RPRX | SELL | 2021-07-27 | $712K | — | Filing → |